sodium apolate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
4705 25053-27-4

Description:

MoleculeDescription

Synonyms:

  • sodium apolate
  • apolate sodium
  • ethenesulfonic acid polymer sodium salt
  • lyapolate sodium
sulfonic acid polymers represent a new class of HIV inhibitors
  • Molecular weight:
  • Formula: (C2H3NaO3S)n
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC C05BA02 CARDIOVASCULAR SYSTEM
VASOPROTECTIVES
ANTIVARICOSE THERAPY
Heparins or heparinoids for topical use

Related Drugs by ATC class:

C05BA Heparins or heparinoids for topical use 2 drugs
heparinpentosan polysulfate

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
CHEBI:755637 CHEBI
CHEMBL3559670 ChEMBL_ID
DB13477 DRUGBANK_ID
52259 RXNORM
007053 NDDF
C0126367 UMLSCUI
1695 INN_ID
C008959 MESH_SUPPLEMENTAL_RECORD_UI
9461405D9F UNII

Pharmaceutical products:

None